Keep in check, the dilution , would happen anyway, the note was due AMBS asks LPC buy 500K worth of shares to pay note or create deal with Dominion. So we are talking roughly 6mil shares to pay the note , Shares from LPC draw down the capital in the agreement (Out of money again if that happens). LPC (or myself would cringe) because I already have set agreement at .06, I don't want two cents. So I figure LPC, Dominion and Kegal restructured the deal with the 12% notes, which to me is a good deal. Dominion shares can"t come to market for 6 months ( The new agreement, Dominion is dumping old shares now, old agreement was .03), there will be another run when AMBS the sale of LYMPRO is announced (IMO), I will sell then and buy back. I am guessing the new clinical will be stage 2. This is just my thoughts
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links